Insider filing · MNPR
Kim R Tsuchimoto
Director
profile →
Monopar Therapeutics Inc.
MNPR · Healthcare · 14 filings in 24 months
ticker →
Kim R Tsuchimoto sold $356K of Monopar Therapeutics (MNPR)
Executed Jul 14 2025, disclosed Jul 16 2025, 2 days later.
Value, as filed
$356K
8,904 sh × $40.00
Executed
Jul 14 2025
the trade date, as filed
Disclosed
Jul 16 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KTKim R Tsuchimoto (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $123K of MNPR (1,098 sh × $111.84, as filed), executed Aug 26.
The name
MNPRHealthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kim R Tsuchimoto in MNPR
MNPRSALE
Monopar Therapeutics Inc.
$123K1,098 sh × $111.84
Exec Aug 26
Filed Aug 28 · 8:18 PM ET MNPRSALE Monopar Therapeutics Inc. $123K
1,098 sh × $111.84
Exec Aug 26
Filed Aug 27 · 6:28 PM ET